{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:31:29Z","timestamp":1792427489461,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.healun.2015.03.002","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T23:48:35Z","timestamp":1429832915000},"page":"1050-1057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy"],"prefix":"10.1016","volume":"34","author":[{"given":"Guillaume","family":"Coutance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Ouldamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Rouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Saheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Suberbielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Br\u00e9chot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hariri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Leprince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaida","family":"Varnous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2015.03.002_bib1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.healun.2015.03.002_bib2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.5414\/CN107156","article-title":"Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation","volume":"77","author":"Sureshkumar","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.healun.2015.03.002_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.healun.2010.11.003","article-title":"Report from a consensus conference on antibody-mediated rejection in heart transplantation","volume":"30","author":"Kobashigawa","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/TP.0b013e318244f7b8","article-title":"Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody","volume":"93","author":"Hodges","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2015.03.002_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/TP.0b013e31829434d4","article-title":"Early versus late acute antibody-mediated rejection in renal transplant recipients","volume":"96","author":"D\u00f6rje","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2015.03.002_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.healun.2011.10.009","article-title":"A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation","volume":"31","author":"Kfoury","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20142010","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib11","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/ajt.12162","article-title":"A survey of current practice for antibody-mediated rejection in heart transplantation","volume":"13","author":"Chih","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib12","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.transproceed.2012.09.123","article-title":"Plasma exchange and intravenous immunoglobulin in the treatment of antibody-mediated rejection after kidney transplantation: a single-center historic cohort study","volume":"45","author":"Gubensek","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2015.03.002_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib14","first-page":"475","article-title":"Bortezomib for refractory antibody-mediated cardiac allograft rejection","author":"Eckman","year":"2009","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2015.03.002_bib15","first-page":"229","article-title":"Elimination of post-transplant donor-specific HLA antibodies with bortezomib","author":"Idica","year":"2008","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2015.03.002_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.healun.2005.10.004","article-title":"Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis","volume":"25","author":"Kirklin","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.healun.2009.04.035","article-title":"Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection","volume":"28","author":"Kfoury","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.healun.2009.01.015","article-title":"Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes","volume":"28","author":"Wu","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib19","first-page":"127","article-title":"Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporine-treated heart transplant recipients","volume":"6","author":"Herskowitz","year":"1987","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2015.03.002_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1432-2277.1995.tb01539.x","article-title":"Plasmapheresis as a rescue therapy to resolve cardiac rejection with vasculitis and severe heart failure. A report of five cases","volume":"8","author":"Berglin","year":"1995","journal-title":"Transpl Int"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249815010980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249815010980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:30:09Z","timestamp":1760949009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249815010980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1053249815010980"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2015.03.002","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2015.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}